Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration
XTalks
AUGUST 30, 2022
Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019. Direct CNS administration is also FDA-approved for multiple small molecules and ASOs. Targeting the CNS directly has been successful in modern medicine.
Let's personalize your content